Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Retinal imaging prevention and early detection of chronic diseases

Project description

Automatic diabetic retinopathy screening solution

Various chronic diseases, such as diabetes, cause changes in the microvasculature of the retina. Detection of these changes takes place through retinal examination and screening, requiring physicians with specific skills and experience. The increasing prevalence of diabetes makes it difficult for healthcare systems worldwide to meet patient demands, necessitating automatised approaches. The EU-funded RETINAL project has developed a non-invasive and cost-effective ICT solution that comprises a digital image capture device, patient data management platform and specialised AI software for diabetic retinopathy screening. The software can quantify retinal parameters and detect lesions of the disease. Its implementation in primary health centres will make diabetic retinopathy screening more accessible to patients and therefore more effective.

Objective

The overall objective of the RETINAL initiative of ULMA Embedded Solutions is to develop non-invasive and cost-effective tools with capacity for prevention and/or early detection of various diseases related to NCD complications, by analyzing the changes in the microvasculature of the retina.The basic framework of RETINAL is a comprehensive solution for ophthalmic imaging analysis and treatment composed of a simple, reliable and cost-effective color fundus digital image capture device and several specific software modules associated to the device for a number of specific clinical applications.The goal of this action is to demonstrate in the market, by independent peers, that RETINAL is the best available and cost-effective technology for the detection of diabetic retinopathy in DR Screening Programmes, and particularly valuable for its implementation at primary health centres, which makes screening more accessible to patients and therefore more effectiveThe overall objective of the RETINAL initiative of ULMA Embedded Solutions is to develop non-invasive and cost-effective tools with capacity for prevention and/or early detection of various diseases related to NCD complications, by analyzing the changes in the microvasculature of the retina.The basic framework of RETINAL is a comprehensive solution for ophthalmic imaging analysis and treatment composed of a simple, reliable and cost-effective color fundus digital image capture device and several specific software modules associated to the device for a number of specific clinical applications.The goal of this action is to demonstrate in the market, by independent peers, that RETINAL is the best available and cost-effective technology for the detection of diabetic retinopathy in DR Screening Programmes, and particularly valuable for its implementation at primary health centres, which makes screening more accessible to patients and therefore more effective

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

SME-2 - SME instrument phase 2

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-SMEInst-2016-2017

See all projects funded under this call

Coordinator

ULMA MEDICAL TECHNOLOGIES SL
Net EU contribution
€ 1 457 662,50
Address
GARAGALTZA AUZOA 51
20560 Onati
Spain
SME
Yes
Region
Noreste País Vasco Gipuzkoa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 2 082 375,00